REFERENCES
- H. G. Brittain. (2002). Effects of mechanical processing on phase composition. J. Pharm. Sci. 91:1573–1580.
- S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and G. Poochikian. (1995). Pharmaceuticals solids, a strategic approach to regulatory considerations. Pharm. Res. 12:945–954.
- G. Chawla, and A. K. Bansal. (2004). Effect of processing on Celecoxib and its solvates. Pharm. Dev. Technol 9:419–433.
- K. H. Chen, W. T. Cheng, M. J. Li, D. M. Yang, and S. Y. Lin. (2005). Calcification of senile cataractous lens determined by Fourier transform infrared (FTIR) and Raman microspectroscopies. J. Microsc. 219:36–41.
- G. G. Ferenczy, L. Párkányi, J. G. Ángyán, A. Kálmán, and B. Hegedüs. (2000). Crystal and electronic structure of two polymorphic modifications of famotidine. An experimental and theoretical study. J. Mol. Struct. (Theochem) 503:73–79.
- M. A. Hassan, M. S. Salem, M. S. Sueliman, and N. M. Najib. (1997). Characterization of famotidine polymorphic forms. Int. J. Pharm. 149:227–232.
- B. Hegedus, P. Harsanyi Bod, K. Peter, I. A. Kalman, and L. Parkany. (1989). Comparison of the polymorphic modifications of famotidine. J. Pharm. Biomed. Anal. 7:563–569.
- T. C Hu, S. L Wang, T. F Chen, and S. Y. Lin. (2002). Hydration-induced proton transfer in the solid state of norfloxacin. J. Pharm. Sci. 91:1351–1357.
- M. Koivisto, P. Heinanen, V. P. Tanninen, and V. P. Lehto. (2006). Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction. Pharm. Res. 23:813–820.
- S. Y Lin, W. T. Cheng, and S. L. Wang. (2006). Thermodynamic and kinetic characterization of polymorphic transformation of famotidine during grinding. Int. J. Pharm. 318:86–91.
- S. Y. Lin, K. H. Chen, W. T. Cheng, C. T. Ho, and S. L. Wang. (2007). Preliminary identification of β-Carotene in the vitreous asteroid bodies by micro-Raman Spectroscopy and HPLC analysis. Microsc. Microanal. 13:128–132.
- K. R. Morris, U. J. Griesser, C. J. Eckhardt, and J. G. Stowell. (2001). Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv. Drug Deliv. Rev. 48:91–114.
- Z. Német, B. Hegedüs, C. Szántay, J. Sztatisz, and G. Pokol. (2005). Pressurization effects on the polymorphic forms of famotidine. Thermochim. Acta. 430:35–41.
- T. Okumura, M. Ishida, K. Takayama, and M. Otsuka. (2006). Polymorphic transformation of indomethacin under high pressures. J. Pharm. Sci. 95:689–700.
- S. W Ray, J. Secrest, A. P. Ch'ien, and R. S. Corey. (2002). Managing gastroesophageal reflux disease. Nurse Pract. 27:36–55.
- M. V. Roux, J. Z. Dávalos, and P. Jiménez. (2002). Effect of pressure on the polymorphic forms of Famotidine. Thermochim. Acta. 394:19–24.
- F. X. Sanchez-Castillo, J. Anwar, and D. M. Heyes. (2003). Molecular dynamics simulations of granular compaction: The single granule case. J. Chem. Phys 118:4636–4648.
- C. N. V. Shekar, and K. G. Rajan. (2001). Kinetics of pressure induced structural phase transitions—A review. Bull. Mater. Sci. 24:1–21.
- D. Singhal, and W. Curatolo. (2004). Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Deliv. Rev. 56:335–347.
- S. R. Vippagunta, H. G. Brittain, and D. J. Grant. (2001). Crystalline solids. Adv. Drug Deliv. Rev. 48:3–26.